PDF
Progress Toward Achieving and Sustaining Maternal and Neonatal Tetanus Elimination — Worldwide, 2000–2020
Organization: United States Centers for Disease Control (CDC)Published: 2022
"During 2000–2020, 47 countries achieved elimination of MNT, reported neonatal tetanus cases decreased 88%, and estimated deaths declined 92%. Other countries are struggling to maintain elimination. To achieve MNT elimination in remaining priority countries and to maintain it globally, efforts are needed to enhance routine vaccination, integrate tetanus activities with other health activities, and promote a life-course vaccination approach for tetanus protection." - Progress Toward Achieving and Sustaining Maternal and Neonatal Tetanus Elimination — Worldwide, 2000–2020
Resource Group:
Evidence
Product Type: Report
Vaccine Monitoring and Surveillance
Vaccination Coverage and Goals
Vaccine Preventable Disease Surveillance
Global Surveillance
Vaccine Preventable Diseases
Non-communicable Disease
Tetanus (Lockjaw)
Product Type: Report
Category:
Monitoring and Surveillance,Vaccine Monitoring and Surveillance,Vaccination Coverage and Goals,Vaccine Preventable Disease Surveillance,Global Surveillance,Vaccine Preventable Diseases,Non-communicable Disease,Tetanus (Lockjaw) Monitoring and SurveillanceVaccine Monitoring and Surveillance
Vaccination Coverage and Goals
Vaccine Preventable Disease Surveillance
Global Surveillance
Vaccine Preventable Diseases
Non-communicable Disease
Tetanus (Lockjaw)
Audience:
Health Care Professional
Population: Children (All)
Adolescents
Pregnant and Breastfeeding People
Region: United States
Population: Children (All)
Adolescents
Pregnant and Breastfeeding People
Region: United States
Language:
English
LinkResource Rating Breakdown
Ratings submitted by CANVax users for this resource are tallied to provide an average resource rating per category.
0 Comments
Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.
All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.
You must login or register before you can submit a comment.